Virginiamycin S1

From WikiMD's WELLNESSPEDIA

Virginiamycin S1


Virginiamycin S1 is a streptogramin antibiotic that is part of the virginiamycin complex. It is produced by the bacterium Streptomyces virginiae. Virginiamycin S1 is used in combination with virginiamycin M1 in the treatment of various bacterial infections.

History[edit]

Virginiamycin S1 was first isolated in the 1950s from Streptomyces virginiae found in soil samples from the state of Virginia, United States. The antibiotic was named after the state where the bacterium was first discovered.

Structure and Mechanism[edit]

Virginiamycin S1 is a macrolide antibiotic. It has a large, complex structure that allows it to bind to the 50S ribosomal subunit of bacteria, inhibiting protein synthesis. This action is synergistic with that of virginiamycin M1, which binds to a different site on the 50S subunit, leading to a more effective inhibition of protein synthesis.

Medical Use[edit]

Virginiamycin S1 is used in combination with virginiamycin M1 to treat infections caused by Gram-positive bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Enterococcus faecium. The combination of the two antibiotics is more effective than either one alone due to their synergistic action.

Side Effects and Precautions[edit]

Like all antibiotics, virginiamycin S1 can cause side effects, including allergic reactions, nausea, vomiting, and diarrhea. It should be used with caution in patients with a history of allergy to macrolide antibiotics.

Resistance[edit]

Resistance to virginiamycin S1 can occur through several mechanisms, including modification of the antibiotic target site, active efflux of the antibiotic, and enzymatic inactivation of the antibiotic. The development of resistance is a major concern in the use of virginiamycin S1 and other antibiotics.

See Also[edit]

WikiMD logo

This article is a stub

You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories.

Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia.


Types of antibacterials




This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.